Search Results 661-670 of 18927 for creatine

1. A Study to Evaluate the Safety and Diagnostic Effectiveness of Mangoral in Patients With Focal Liver Lesions and Reduced Kidney Function - Mayo Clinic

   ... creatinine ≥ 0.3 mg/dL within 48 hours or ≥ 50% within 7 days prior to the. Baseline Visit. Exclusion Criteria: - Participants with simple liver cysts only ...

2. Ulixertinib in People With Histiocytic Neoplasms - Mayo Clinic

   Participation eligibility · Adequate renal function (according to the Cockcroft-Gault equation; creatinine ≤1.5 times upper limit of normal [ULN] or a ...

3. Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment - Mayo Clinic

   Serum creatinine ≤1.5 x upper limit of normal (ULN) or calculated creatinine clearance ≥50 mL/min using Cockcroft-Gault equation;; Total bilirubin ≤1.5 ...

4. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

   Participation eligibility · Creatinine ≤ 2 mg/dL · Calculated Creatinine Clearance ≥ 30 mL/min · Total Bilirubin ≤ 2.0 mg/dL · Alkaline Phosphatase ≤ 3 x ULN ...

5. A Study to Evaluate the Effectiveness, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

   Adequate renal function assessed by serum creatinine within reference lab normal limits OR creatinine clearance ≥ 50 mL/min calculated by the Cockcroft Gault.

6. Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) (enrollment by invitation only) - Mayo Clinic

   Creatinine clearance < 50 mL/min using the Cockcroft-Gault formula for participants ≥ 18 years of age {Cockcroft 1976} and Schwartz Formula for ...

7. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   Participants can be on stable dose of erythropoietin (>= approximately 3 months). - Creatinine clearance (CrCl) >= 30 mL/min (within 14 days of registration) - ...

8. Oxaliplatin, Leucovorin Calcium, and Fluorouracil with or without Celecoxib in Treating Patients with Stage III Colon Cancer Previously Treated with Surgery - Mayo Clinic

   Required initial laboratory values. Granulocytes ≥ 1,500/μL; Platelet count ≥ 100,000/μL; Creatinine ≤ 1.5 times upper limit of normal (ULN); Total Bilirubin ...

9. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

   Creatinine ≤ 2.0 mg/dL, and/or. Creatinine clearance (estimated GFR [Cockcroft-Gault]) ≥30 mL/min. Total bilirubin ≤ 1.5 x ULN (unless disease related or ...

10. Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells - Mayo Clinic

    Individuals not eligible for MRI and have elevated serum creatinine level (eGFR less that 45 mL/min) and therefore cannot have a CT examination; Individuals ...